Pure Global

Quit Smoking Text Message Study - Trial NCT06111755

Access comprehensive clinical trial information for NCT06111755 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06111755
Not yet recruiting
other
Trial Details
ClinicalTrials.gov • NCT06111755
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Quit Smoking Text Message Study
Evaluating Digital Health Interventions To Promote Smoking Cessation

Study Focus

Smoking Cessation

SmokefreeTXT

Interventional

other

Sponsor & Location

Yale University

Timeline & Enrollment

N/A

Nov 01, 2023

Jun 01, 2025

200 participants

Primary Outcome

Number of participants with cotinine confirmed 7-day point-prevalence abstinence (PPA) at end of treatment (8 weeks)

Summary

This project will address research gaps and advance the science of smoking cessation by
 conducting a randomized controlled trial of an evidence-based, population-level quit smoking
 text messaging program with or without a smartband.

ICD-10 Classifications

Mental and behavioural disorders due to use of tobacco withdrawal state
Tobacco use
Exposure to tobacco smoke
Toxic effect: Tobacco and nicotine
Mental and behavioural disorders due to use of tobacco

Data Source

ClinicalTrials.gov

NCT06111755

Non-Device Trial